Poly-L-lysine/hyaluronan nanocarriers as a novel nanosystem for gene delivery
- PMID: 35443072
- DOI: 10.1111/jmi.13107
Poly-L-lysine/hyaluronan nanocarriers as a novel nanosystem for gene delivery
Abstract
The present research comes up with a novel DNA-loaded poly-L-lysine (PLL)/hyaluronan (HA) nanocarrier (DNA-loaded PLL/HA NCs) for gene delivery applications, as a promising candidate for gene delivery into diverse cells. A straightforward approach was employed to prepare such a nanosystem through masking DNA-loaded PLL molecules by HA. Fourier-transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), field emission-scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) were used to analyse the interaction of the molecules as well as the physicochemical properties of the NCs. The NCs showed a negative charge of -24 ± 3 mV, with an average size of 138 ± 6 nm, in an ellipsoid-shape with smooth surfaces. The DNA loading efficiency (LE) measured by DNA absorbance was around 95 %. The MTT assay showed that the developed NCs are non-toxic to the cells. Furthermore, the uptake of the DNA-loaded PLL/HA NCs by the human embryonic kidney (HEK)-293T cells was evaluated by a flow cytometry method, and demonstrated high potential cellular uptake over 90% for transferring the gene to HEK-293T cells at the optimised conditions. Therefore, the DNA-loaded PLL/HA NCs are the potent strategy for developing nanosystems for gene delivery applications.
Keywords: gene delivery; hyaluronan; nanocarriers; poly-L-lysine.
© 2022 Royal Microscopical Society.
References
REFERENCES
-
- Jiang, B., He, H., Yao, L., Zhang, T., Huo, J., & Sun, W. (2017). Harmonizing the intracellular kinetics toward effective gene delivery using cancer cell-targeted and light-degradable polyplexes. Biomacromolecules, 18(3), 877-885.
-
- Gillet, J.-P., Macadangdang, B., Fathke, R. L., Gottesman, M. M., & Kimchi-Sarfaty, C. (2009). The development of gene therapy: From monogenic recessive disorders to complex diseases such as cancer. Gene Therapy of Cancer: Methods and Protocols, 542, 5-54.
-
- Mofazzal Jahromi, M. A., Hosseini, S. Y., Bozorgmehr, M., Baesi, K., Azadmanesh, K., & Hassan, Z. M. (2014). Adenovirus-mediated overexpression of gamma interferon in murine bone marrow-derived dendritic cells affects their viability and activity. Asian Pacific Journal of Tropical Disease, 4, S353-S359.
-
- Liu, F., & Huang, L. (2002). Development of non-viral vectors for systemic gene delivery. Journal of Controlled Release, 78(1), 259-266.
-
- Segura, T., & Shea, L. D. (2001). Materials for non-viral gene delivery. Annual Review of Materials Research, 31(1), 25-46.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
